-
EP4288519
Procédure d'examen
Extrait du Registre européen des brevets
EP Présentation générale: EP4288519
| EP4288519 - ASSEMBLED THREE-DIMENSIONAL CULTURES OF HUMAN NEURONS AND GLIA AND THEIR USE [Cliquez sur ce lien avec le bouton droit de la souris pour le conserver dans vos signets] | Statut | La requête en examen a été présentée Statut actualisé le 10.11.2023 Base de données mise à jour au 24.03.2026 | |
| Précédent | La publication internationale a été faite Statut actualisé le 03.09.2022 | Dernier événement Tooltip | 03.03.2026 | Nouvelle entrée: taxe annuelle payée | Demandeur(s) | Pour tous les Etats désignés The Regents of University of California 1111 Franklin Street, 12th Floor Oakland, CA 94607-5200 / US | [2023/50] | Inventeur(s) | 01 /
ULLIAN, Erik M. San Francisco, California 94143 / US | 02 /
KOONTZ, Mark San Francisco, California 94143 / US | 03 /
KRENCIK, Robert San Francisco, California 94143 / US | [2023/50] | Mandataire(s) | Williams Powell 330 High Holborn London WC1V 7QH / GB | [N/P] |
| Précédent [2023/50] | Williams Powell 44 Prospect Place Bromley, Kent BR2 9HN / GB | Numéro de la demande, date de dépôt | 22760500.3 | 25.02.2022 | [2023/50] | WO2022US17942 | Numéro de priorité, date | US202163154305P | 26.02.2021 Format original publié: US 202163154305 P | US202163215179P | 25.06.2021 Format original publié: US 202163215179 P | [2023/50] | Langue de dépôt | EN | Langue de la procédure | EN | Publication | Type: | A1 Demande avec rapport de recherche | N°: | WO2022183015 | Date: | 01.09.2022 | Langue: | EN | [2022/35] | Type: | A1 Demande avec rapport de recherche | N°: | EP4288519 | Date: | 13.12.2023 | Langue: | EN | La demande publiée par l'OMPI le 01.09.2022, dans une des langues officielles de l'OEB, remplace la publication de la demande de brevet européen. | [2023/50] | Rapport(s) de recherche | Rapport de recherche internationale - publié le: | US | 01.09.2022 | Rapport (complémentaire) de recherche européenne - envoyé le: | EP | 24.02.2025 | Classification | IPC: | C12M3/00, C12N5/00 | [2023/50] | CPC: |
C12N5/0619 (EP,US);
C12N5/0622 (EP,US);
C12N15/113 (EP);
C12N9/22 (EP,US);
G01N33/5058 (US);
C12N2310/20 (EP,US);
C12N2501/11 (US);
C12N2501/115 (US);
C12N2501/13 (EP,US);
C12N2501/155 (EP);
C12N2501/40 (US);
C12N2501/727 (EP);
C12N2503/04 (US);
C12N2506/08 (US);
C12N2506/45 (EP);
| Etats contractants désignés | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/50] | Titre | Allemand: | ZUSAMMENGESETZTE DREIDIMENSIONALE KULTUREN VON MENSCHLICHEN NEURONEN UND GLIA UND IHRE VERWENDUNG | [2023/50] | Anglais: | ASSEMBLED THREE-DIMENSIONAL CULTURES OF HUMAN NEURONS AND GLIA AND THEIR USE | [2023/50] | Français: | CULTURES TRIDIMENSIONNELLES ASSEMBLÉES DE NEURONES ET DE GLIE HUMAINS ET LEUR UTILISATION | [2023/50] | Entrée dans la phase régionale | 04.09.2023 | Taxe nationale de base payée | 04.09.2023 | Taxe de recherche payée | 04.09.2023 | Taxe(s) de désignation payée(s) | 04.09.2023 | Taxe d'examen payée | Procédure d'examen | 04.09.2023 | Requête en examen déposée [2023/50] | 04.08.2025 | Modification par le demandeur (revendications et/ou déscription) | 04.08.2025 | Date à laquelle la division d’examen est devenue compétente | Taxes payées | Taxe annuelle | 27.02.2024 | Taxe annuelle Année du brevet 03 | 27.02.2025 | Taxe annuelle Année du brevet 04 | 27.02.2026 | Taxe annuelle Année du brevet 05 |
| Dérogation à la compétence Tooltip exclusive de la juridiction unifiée du brevet | Voir le Registre de la juridiction unifiée du brevet pour les données relatives à la dérogation | ||
| La juridiction unifiée du brevet assume l'entière responsabilité de l'exactitude, de l'exhaustivité et de la qualité des données présentées sous le lien fourni. | Citations: | Recherche | [X] WO2017060884 (UNIVERSITÉ DU LUXEMBOURG et al.) | [XY] US2020386742 (MOORE MICHAEL JAMES et al.) | [P] WO2016141137 (HARVARD COLLEGE et al.) | [P] ORMEL PAUL R. ET AL: "Microglia innately develop within cerebral organoids | Nature Communications", NATURE COMMUNICATIONS, vol. 9, no. 1, 9 October 2018 (2018-10-09), UK, XP093248833, ISSN: 2041-1723, Retrieved from the Internet DOI: http://dx.doi.org/10.1038/s41467-018-06684-2 | [P] WEI NIU ET AL: "Modeling genetic epilepsies in a dish", DEVELOPMENTAL DYNAMICS, WILEY-LISS INC NEW YORK , NY, US, vol. 249, no. 1, 11 July 2019 (2019-07-11), pages 56 - 75, XP071972121, ISSN: 1058-8388, DOI: 10.1002/DVDY.79 [P] DOI: http://dx.doi.org/10.1002/dvdy.79 | [X] MCCAUGHEY-CHAPMAN AMY ET AL: "Human Cortical Neuron Generation Using Cell Reprogramming: A Review of Recent Advances", STEM CELLS AND DEVELOPMENT, vol. 27, no. 24, 15 December 2018 (2018-12-15), US, pages 1674 - 1692, XP055795198, ISSN: 1547-3287, Retrieved from the Internet DOI: http://dx.doi.org/10.1089/scd.2018.0122 | [XY] GIACOMO MASSERDOTTI ET AL: "Direct neuronal reprogramming: learning from and for development", DEVELOPMENT, vol. 143, no. 14, 15 July 2016 (2016-07-15), GB, pages 2494 - 2510, XP055728015, ISSN: 0950-1991, DOI: 10.1242/dev.092163 [Y] 1-19 DOI: http://dx.doi.org/10.1242/dev.092163 | [Y] NISHA R IYER ET AL: "Stem cells for spinal cord injury: Strategies to inform differentiation and transplantation", BIOTECHNOLOGY AND BIOENGINEERING, JOHN WILEY, HOBOKEN, USA, vol. 114, no. 2, 21 September 2016 (2016-09-21), pages 245 - 259, XP071113864, ISSN: 0006-3592, DOI: 10.1002/BIT.26074 [Y] 1-22 * figures 1-4 * DOI: http://dx.doi.org/10.1002/bit.26074 | Recherche internationale | [XY] US2020386742 (MOORE MICHAEL JAMES et al.) [X] 1-3, 36, 59-61 * entire document *[Y] 4, 37, 38 | [Y] US2018021383 (GEORGE MATT et al.) [Y] 38 * entire document * | [Y] FREGA ET AL.: "Rapid Neuronal Differentiation of Induced Pluripotent Stem Cells for Measuring Network Activity on Micro-electrode Arrays", JOVE JOURNA L, 8 January 2017 (2017-01-08), XP055965101, Retrieved from the Internet DOI: http://dx.doi.org/10.3791/54900 | [Y] XIN ET AL.: "Ventral midbrain astrocytes display unique physiological features and sensitivity to dopamine D2 receptor signaling", NEUROPSYCHOPHARMACOLOG Y, vol. 44, 13 July 2018 (2018-07-13), pages 344 - 355, XP036660280, DOI: 10.1038/s41386-018-0151-4 [Y] 37 * . entire document * DOI: http://dx.doi.org/10.1038/s41386-018-0151-4 | [A] B AGYINSZKY ET AL.: "Early-onset Alzheimer's disease patient with prion (PRNP) p.Vall80lle mutation", NEUROPSYCHIATRIC DISEASE AND TREATMENT, vol. 15, 16 July 2019 (2019-07-16), pages 2003 - 2013, XP055965106 [A] 1-4, 36-38, 59-61 * . entire document * DOI: http://dx.doi.org/10.2147/NDT.S215277 | par le demandeur | US4458066 | US4415732 | US4568649 | US5989833 | DAWSON, T. MGOLDE, T. ELAGIER-TOURENNE, C: "Animal models of neurodegenerative diseases", NAT NEUROSCI, vol. 21, 2018, pages 1370 - 1379, XP036600691, DOI: 10.1038/s41593-018-0236-8 [A] 1-4, 36-38, 59-61 * . entire document * DOI: http://dx.doi.org/10.1038/s41593-018-0236-8 | "Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease", N ENGL J MED, vol. 345, 2001, pages 956 - 963 | KAO, A. WMCKAY, ASINGH, P. PBRUNET, AHUANG, E. J. PROGRANULIN: "lysosomal regulation and neurodegenerative disease", NAT REV NEUROSCI, vol. 18, 2017, pages 325 - 333 | CHOI, S. H ET AL.: "A three-dimensional human neural cell culture model of Alzheimer's disease", NATURE, vol. 515, 2014, pages 274 - 278, XP055394768, DOI: 10.1038/nature13800 DOI: http://dx.doi.org/10.1038/nature13800 | GONZALEZ ET AL., PSYCHIATRY, vol. 23, 2018, pages 2363 - 2374 | KIM, Y. H ET AL.: "A 3D human neural cell culture system for modeling Alzheimer's disease", NAT PROTOC, vol. 10, 2015, pages 985 - 1006 | KWAK, S. S. ET AL.: "Amyloid-beta42/40 ratio drives tau pathology in 3D human neural cell culture models of Alzheimer's disease", NAT COMMUN, vol. 11, 2020, pages 1377 | LEE, H. K. ET AL.: "Three Dimensional Human Neuro-Spheroid Model of Alzheimer's Disease Based on Differentiated Induced Pluripotent Stem Cells", PLOS ONE, vol. 11, 2016, pages 0163072 | YAN, Y. ET AL.: "Modeling Neurodegenerative Microenvironment Using Cortical Organoids Derived from Human Stem Cells", TISSUE ENG PART A, vol. 24, 2018, pages 1125 - 1137, XP093270442, DOI: 10.1089/ten.tea.2017.0423 DOI: http://dx.doi.org/10.1089/ten.tea.2017.0423 | PENNEY, J.RALVENIUS, W. TTSAI, L. H: "Modeling Alzheimer's disease with iPSC-derived brain cells", MOL PSYCHIATRY, vol. 25, 2020, pages 148 - 167, XP036953776, DOI: 10.1038/s41380-019-0468-3 DOI: http://dx.doi.org/10.1038/s41380-019-0468-3 | HERNANDEZ-SAPIENS, M. A ET AL.: "A Three-Dimensional Alzheimer's Disease Cell Culture Model Using iPSC-Derived Neurons Carrying A246E Mutation in PSEN1", FRONT CELL NEUROSCI, vol. 14, 2020, pages 151 | SLANZI, ALANNOTO, GROSSI, BZENARO, ECONSTANTIN, G: "In vitro Models of Neurodegenerative Diseases", FRONT CELL DEV BIOL, vol. 8, 2020, pages 328 | CHOI, S. HKIM, Y. HQUINTI, LTANZI, R. EKIM, D. Y: "3D culture models of Alzheimer's disease: a road map to a ''cure-in-a-dish", MOL NEURODEGENER, vol. 11, 2016, pages 75 | WU, Y. YCHIU, F. LYEH, C. SKUO, H. C.: "Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease", OPEN BIOL, vol. 9, 2019, pages 180177 | MOFAZZAL JAHROMI, M. A ET AL.: "Microfluidic Brain-on-a-Chip: Perspectives for Mimicking Neural System Disorders", MOL NEUROBIOL, vol. 56, 2019, pages 8489 - 8512, XP036926924, DOI: 10.1007/s12035-019-01653-2 DOI: http://dx.doi.org/10.1007/s12035-019-01653-2 | BORDONI ET AL.: "From Neuronal Differentiation of iPSCs to 3D Neuro-Organoids:Modelling and Therapy of Neurodegenerative Diseases", INT J MOL SCI, vol. 19, 2018, pages 19 | KORHONEN, PMALM, TWHITE, A. R: "3D human brain cell models: New frontiers in disease understanding and drug discovery for neurodegenerative diseases", NEUROCHEM INT, vol. 120, 2018, pages 191 - 199, XP085485782, DOI: 10.1016/j.neuint.2018.08.012 DOI: http://dx.doi.org/10.1016/j.neuint.2018.08.012 | CENTENO, E. G. ZCIMAROSTI, HBITHELL, A: "2D versus 3D human induced pluripotent stem cell-derived cultures for neurodegenerative disease modelling", MOL NEURODEGENER, vol. 13, 2018, pages 27, XP055681146, DOI: 10.1186/s13024-018-0258-4 DOI: http://dx.doi.org/10.1186/s13024-018-0258-4 | POON, A ET AL.: "Modeling neurodegenerative diseases with patient-derived induced pluripotent cells: Possibilities and challenges", N BIOTECHNOL, vol. 39, 2017, pages 190 - 198, XP085214603, DOI: 10.1016/j.nbt.2017.05.009 DOI: http://dx.doi.org/10.1016/j.nbt.2017.05.009 | LEE, C. TBENDRIEM, R. MWU, W. WSHEN, R. F: "3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders", J BIOMED SCI, vol. 24, 2017, pages 59, XP055881808, DOI: 10.1186/s12929-017-0362-8 DOI: http://dx.doi.org/10.1186/s12929-017-0362-8 | SON, M. Y ET AL.: "Distinctive genomic signature of neural and intestinal organoids from familial Parkinson's disease patient-derived induced pluripotent stem cells", NEUROPATHOL APPL NEUROBIOL, vol. 43, 2017, pages 584 - 603 | KIM, H ET AL.: "Modeling G2019S-LRRK2 Sporadic Parkinson's Disease in 3D Midbrain Organoids", STEM CELL REPORTS, vol. 12, 2019, pages 518 - 531 | MIGUEL, L ET AL.: "Detection of all adult Tau isoforms in a 3D culture model of iPSC-derived neurons", STEM CELL RES, vol. 40, 2019, pages 101541, XP085865409, DOI: 10.1016/j.scr.2019.101541 DOI: http://dx.doi.org/10.1016/j.scr.2019.101541 | BOLOGNIN ET AL., ADV SCI, vol. 6, 2019, pages 1800927 | ARAI, T. ET AL.: "TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.", BIOCHEM BIOPHYS RES COMMUN, vol. 351, 2006, pages 602 - 611, XP024925727, DOI: 10.1016/j.bbrc.2006.10.093 DOI: http://dx.doi.org/10.1016/j.bbrc.2006.10.093 | NEUMANN, M. ET AL.: "Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.", SCIENCE, vol. 314, 2006, pages 130 - 133, XP002534603, DOI: 10.1126/SCIENCE.1134108 DOI: http://dx.doi.org/10.1126/SCIENCE.1134108 | VATSAVAYAI, S. C.NANA, A. L.YOKOYAMA, J. S.SEELEY, W. W.: "C9orf72-FTD/ALS pathogenesis: evidence from human neuropathological studies.", ACTA NEUROPATHOL, vol. 137, 2019, pages 1 - 26, XP036677364, DOI: 10.1007/s00401-018-1921-0 DOI: http://dx.doi.org/10.1007/s00401-018-1921-0 | REYES ET AL., J NEUROSCI, vol. 28, no. 48, 2008, pages 12622 - 12631 | ZHANG, Y. ET AL.: "Rapid single-step induction of functional neurons from human pluripotent stem cells.", NEURON, vol. 78, no. 5, 2013, pages 785 - 798, XP028562742, DOI: 10.1016/j.neuron.2013.05.029 DOI: http://dx.doi.org/10.1016/j.neuron.2013.05.029 | HESTER ET AL., MOL. THER, vol. 19, 2011, pages 1905 - 1912 | FERNANDOPULLE ET AL., CURR. PROTOC. CELL BIOL, vol. 79, no. 1, 2018, pages 51 | KRENCIK ET AL., NAT. PROTOC, vol. 6, no. 11, 2011, pages 1710 - 1717 | YANG ET AL., NAT. METHODS, vol. 14, 2017, pages 621 - 628 | MUFFAT ET AL., NAT. MED, vol. 22, 2016, pages 1358 - 1367 | PANDYA ET AL., NAT. NEUROSCI, vol. 20, 2017, pages 753 - 759 | KRENCIK, R. ET AL.: "Systematic Three-Dimensional Coculture Rapidly Recapitulates Interactions between Human Neurons and Astrocytes.", STEM CELL REPORTS, vol. 9, 2017, pages 1745 - 1753, XP093291570, DOI: 10.1016/j.stemcr.2017.10.026 DOI: http://dx.doi.org/10.1016/j.stemcr.2017.10.026 | ABUD, E. M. ET AL.: "iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases.", NEURON, vol. 94, no. 2, 2017, pages 278 - 293 | NG ET AL., STEM CELL REPORTS, vol. 16, no. 7, 2021, pages 1763 - 1776 | TAKAHASHI ET AL., CELL., vol. 131, no. 5, 2007, pages 861 - 872 | MUFFAT ET AL., MED, vol. 22, 2016, pages 1358 - 1367 | WANG, C. ET AL.: "Scalable Production of iPSC-Derived Human Neurons to Identify Tau-Lowering Compounds by High-Content Screening.", STEM CELL REPORTS, vol. 16, no. 7, 2017, pages 1221 - 1233 | CHYLINSKI ET AL., NUCLEIC ACIDS RES., vol. 42, no. 10, 2014, pages 6091 - 6105 | KAPITONOV ET AL., J. BACTERIOL, vol. 198, no. 5, 2015, pages 797 - 807 | SHMAKOV ET AL., MOL. CELL., vol. 60, no. 3, 2015, pages 385 - 397 | LEDFORD ET AL., NATURE, vol. 526, no. 7571, 2015, pages 17 - 17 | ZETSCHE ET AL., CELL, vol. 163, no. 3, 2015, pages 759 - 771 | MUROVEC ET AL., PLANT BIOTECHNOL. J, vol. 15, no. 8, 2017, pages 917 - 926 | ZHANG ET AL., FRONT. PLANT SCI, vol. 8, 2017, pages 177 | FERNANDES ET AL., POSTEPY BIOCHEM., vol. 62, no. 3, 2016, pages 315 - 326 | SHMAKOV ET AL., MOL CELL, vol. 60, no. 3, 2015, pages 385 - 397 | ZHANG, FRONT PLANT SCI, vol. 8, 2017, pages 177 | HAVLICEK ET AL., MOL. THER., vol. 25, no. 2, 2017, pages 342 - 355 | PAN ET AL., REP, vol. 6, 2016, pages 35794 | TSAI ET AL., NAT BIOTECHNOL., vol. 32, no. 6, 2014, pages 569 - 576 | GILBERT ET AL., CELL, vol. 154, no. 2, 2013, pages 1173 - 1183 | DOMINGUEZ ET AL., NAT. REV. MOL. CELL. BIOL, vol. 17, no. 1, 2016, pages 5 - 15 | BEAUCAGE ET AL., TETRAHEDRON, vol. 48, 1992, pages 2223 - 2311 | APPLIED BIOSYSTEMS USER BULLETIN NO. 13, 1 April 1987 (1987-04-01) | NARANG ET AL., METH. ENZYMOL, vol. 68, 1979, pages 109 | STEPPER ET AL., NUCLEIC ACIDS RES., vol. 45, no. 17, 2017, pages 1703 - 1713 | LUI, H. ET AL.: "Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation.", CELL, vol. 165, no. 1, 2016, pages 921 - 935, XP029530775, DOI: 10.1016/j.cell.2016.04.001 DOI: http://dx.doi.org/10.1016/j.cell.2016.04.001 | LO, F1000RES. 6. PII: F1000 FACULTY REV, 2017, pages 747 | BECKER, L. A. ET AL.: "Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice.", NATURE, vol. 544, 2017, pages 367 - 371, XP055607892, DOI: 10.1038/nature22038 DOI: http://dx.doi.org/10.1038/nature22038 | HAMEED ET AL., MICROB. PATHOG, vol. 133, 2019, pages 103551 | WANG ET AL., BIOTECHNOL ADV, vol. 37, no. 5, 2019, pages 708 - 729 | AMAN ET AL., VIRUSES, vol. 10, no. 12, 2018, pages 732 | ZHANG ET AL., CELL, vol. 175, no. 1, 2018, pages 212 - 223 | GOODMANGILMAN: "The Pharmacological Basis of Therapeutics", 1996, MCGRAW-HILL | DRUGS ACTING AT SYNAPTIC AND NEUROEFFECTOR JUNCTIONAL SITES; CARDIOVASCULAR DRUGS; VITAMINS, DERMATOLOGY; AND TOXICOLOGY | SHMAKOV ET AL., NATURE REVIEWS MICROBIOLOGY, vol. 15, 2017, pages 169 | JONES, TRENDS BIOTECHNOL, vol. 17, no. 12, 1999, pages 477 - 81 | "Confocal Microscopy Methods and Protocols (Methods in Molecular Biology", vol. 122, 1998, HUMANA PRESS | GONZALEZ, C ET AL.: "Modeling amyloid beta and tau pathology in human cerebral organoids", MOL PSYCHIATRY, vol. 23, 2018, pages 2363 - 2374, XP036856747, DOI: 10.1038/s41380-018-0229-8 DOI: http://dx.doi.org/10.1038/s41380-018-0229-8 | BOLOGNIN, S. ET AL.: "3D Cultures of Parkinson's Disease-Specific Dopaminergic Neurons for High Content Phenotyping and Drug Testing.", ADV SCI (WEINH, vol. 6, 2019, pages 1800927 | CRUTS, M. ET AL.: "Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21.", NATURE, vol. 442, 2006, pages 920 - 924, XP008101481, DOI: 10.1038/NATURE05017 DOI: http://dx.doi.org/10.1038/NATURE05017 | WARD, M. E. ET AL.: "Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLD.", J EXP MED, vol. 211, 2014, pages 1937 - 1945 | NGUYEN, A. D. ET AL.: "Murine knockin model for progranulin-deficient frontotemporal dementia with nonsense-mediated mRNA decay.", PROC NATL ACAD SCI U S A, vol. 115, 2018, pages E2849 - E2858, XP055741714, DOI: 10.1073/pnas.1722344115 DOI: http://dx.doi.org/10.1073/pnas.1722344115 | ZHANG, J. ET AL.: "Neurotoxic microglia promote TDP-43 proteinopathy in progranulin deficiency.", NATURE, vol. 588, 2020, pages 459 - 465, XP037317192, DOI: 10.1038/s41586-020-2709-7 DOI: http://dx.doi.org/10.1038/s41586-020-2709-7 | WARD, M. E. ET AL.: "Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis.", SCI TRANSL MED, 2017, pages 9 | ROSEN, E. Y. ET AL.: "Functional genomic analyses identify pathways dysregulated by progranulin deficiency, implicating Wnt signaling.", NEURON, vol. 71, 2011, pages 1030 - 1042, XP028390988, DOI: 10.1016/j.neuron.2011.07.021 DOI: http://dx.doi.org/10.1016/j.neuron.2011.07.021 | LEE, S.HUANG, E. J.: "Modeling ALS and FTD with iPSC-derived neurons.", BRAIN RES, vol. 1656, 2017, pages 88 - 97, XP029896323, DOI: 10.1016/j.brainres.2015.10.003 DOI: http://dx.doi.org/10.1016/j.brainres.2015.10.003 | ALMEIDA, S. ET AL.: "Induced pluripotent stem cell models of progranulin-deficient frontotemporal dementia uncover specific reversible neuronal defects.", CELL REP, vol. 2, 2012, pages 789 - 798 | AHMED, Z. ET AL.: "Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging.", AM J PATHOL, vol. 177, 2010, pages 311 - 324 | KELLEY, K. W.NAKAO-INOUE, H.MOLOFSKY, A. VOLDHAM, M. C: "Variation among intact tissue samples reveals the core transcriptional features of human CNS cell classes.", NAT NEUROSCI, vol. 21, 2018, pages 1171 - 1184, XP036610865, DOI: 10.1038/s41593-018-0216-z DOI: http://dx.doi.org/10.1038/s41593-018-0216-z | ZHANG, Y. ET AL.: "Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse.", NEURON, vol. 89, 2016, pages 37 - 53, XP029381420, DOI: 10.1016/j.neuron.2015.11.013 DOI: http://dx.doi.org/10.1016/j.neuron.2015.11.013 | ZHANG, Y. ET AL.: "An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex.", J NEUROSCI, vol. 34, 2014, pages 11929 - 11947 | HANSEN, D. VHANSON, J. E.SHENG, M.: "Microglia in Alzheimer's disease.", J CELL BIOL, vol. 217, 2018, pages 459 - 472, XP093273015, DOI: 10.1083/jcb.201709069 DOI: http://dx.doi.org/10.1083/jcb.201709069 | VERKHRATSKY, A.OLABARRIA, MNORISTANI, H. N.YEH, C. YRODRIGUEZ, J. J.: "Astrocytes in Alzheimer's disease.", NEUROTHERAPEUTICS, vol. 7, 2010, pages 399 - 412, XP027350963 | DESAI, M. K. ET AL.: "Early oligodendrocyte/myelin pathology in Alzheimer's disease mice constitutes a novel therapeutic target.", AM J PATHOL, vol. 177, 2010, pages 1422 - 1435, XP055158191, DOI: 10.2353/ajpath.2010.100087 DOI: http://dx.doi.org/10.2353/ajpath.2010.100087 | TIAN, R. ET AL.: "CRISPR Interference-Based Platform for Multimodal Genetic Screens in Human iPSC-Derived Neurons", NEURON, vol. 104, 2019, pages 239 - 255 | FERNANDOPULLE, M. S. ET AL.: "Transcription Factor-Mediated Differentiation of Human iPSCs into Neurons.", CURR PROTOC CELL BIOL, vol. 79, 2018, pages e51, XP093266319, DOI: 10.1002/cpcb.51 DOI: http://dx.doi.org/10.1002/cpcb.51 | DAVIDSON, Y. ET AL.: "Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43.", ACTA NEUROPATHOL, vol. 113, 2007, pages 521 - 533, XP019516581, DOI: 10.1007/s00401-006-0189-y DOI: http://dx.doi.org/10.1007/s00401-006-0189-y | DE MAJO, MKOONTZ, MROWITCH, D.ULLIAN, E. M: "An update on human astrocytes and their role in development and disease.", GLIA, vol. 68, 2020, pages 685 - 704, XP071740544, DOI: 10.1002/glia.23771 DOI: http://dx.doi.org/10.1002/glia.23771 | NONHOFF, U. ET AL.: "Ataxin-2 interacts with the DEAD/H-box RNA helicase DDX6 and interferes with P-bodies and stress granules.", MOL BIOL CELL, vol. 18, 2007, pages 1385 - 1396 | KAEHLER, C.: "Ataxin-2-like is a regulator of stress granules and processing bodies.", PLOS ONE, vol. 7, 2012, pages e50134 | LI, Y. RKING, O. DSHORTER, J.GITLER, A. D: "Stress granules as crucibles of ALS pathogenesis.", J CELL BIO, vol. 1201, 2013, pages 361 - 372 | KHALFALLAH, Y. ET AL.: "TDP-43 regulation of stress granule dynamics in neurodegenerative disease-relevant cell types.", SCI REP, vol. 8, 2018, pages 7551 | FENG, T. ET AL.: "Loss of TMEM106B and PGRN leads to severe lysosomal abnormalities and neurodegeneration in mice.", EMBO REP, vol. 21, 2020, pages e50219 | ZHOU, X. ET AL.: "Loss of Tmem106b exacerbates FTLD pathologies and causes motor deficits in progranulin-deficient mice.", EMBO REP, vol. 21, 2020, pages e50197 | TAYEBI, N.LOPEZ, G.DO, J.SIDRANSKY, E: "Pro-cathepsin D, Prosaposin, and Progranulin: Lysosomal Networks in Parkinsonism.", TRENDS MOL MED, vol. 26, 2020, pages 913 - 923, XP086270564, DOI: 10.1016/j.molmed.2020.07.004 DOI: http://dx.doi.org/10.1016/j.molmed.2020.07.004 | KRENCIK, RZHANG, S. C.: "Directed differentiation of functional astroglial subtypes from human pluripotent stem cells.", NAT PROTOC, vol. 6, 2011, pages 1710 - 1717, XP055615854, DOI: 10.1038/nprot.2011.405 DOI: http://dx.doi.org/10.1038/nprot.2011.405 | DI DOMENICO, A. ET AL.: "Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease", STEM CELL REPORTS, vol. 12, 2019, pages 213 - 229, XP093138800, DOI: 10.1016/j.stemcr.2018.12.011 DOI: http://dx.doi.org/10.1016/j.stemcr.2018.12.011 | AFLAKI, E. ET AL.: "A characterization of Gaucher iPS-derived astrocytes: Potential implications for Parkinson's disease.", NEUROBIOL DIS, vol. 134, 2020, pages 104647 | BARBAR, L. ET AL.: "CD49f Is a Novel Marker of Functional and Reactive Human iPSC-Derived Astrocytes.", NEURON, vol. 107, 2020, pages 436 - 453 | ZAMANIAN, J. L. ET AL.: "Genomic analysis of reactive astrogliosis.", J NEUROSCI, vol. 32, 2012, pages 6391 - 6410, XP055773073, DOI: 10.1523/JNEUROSCI.6221-11.2012 DOI: http://dx.doi.org/10.1523/JNEUROSCI.6221-11.2012 | LIDDELOW, S. A. ET AL.: "Neurotoxic reactive astrocytes are induced by activated microglia.", NATURE, vol. 541, 2017, pages 481 - 487, XP055629097, DOI: 10.1038/nature21029 DOI: http://dx.doi.org/10.1038/nature21029 | HERCULANO-HOUZEL, S: "The glia/neuron ratio: how it varies uniformly across brain structures and species and what that means for brain physiology and evolution.", GLIA, vol. 62, 2014, pages 1377 - 1391, XP071739905, DOI: 10.1002/glia.22683 DOI: http://dx.doi.org/10.1002/glia.22683 | PELVIG, D. P.PAKKENBERG, HSTARK, A. KPAKKENBERG, B.: "Neocortical glial cell numbers in human brains.", NEUROBIOL AGING, vol. 29, 2008, pages 1754 - 1762, XP025428369, DOI: 10.1016/j.neurobiolaging.2007.04.013 DOI: http://dx.doi.org/10.1016/j.neurobiolaging.2007.04.013 | MACKENZIE, I. RRADEMAKERS, R.: "The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.", CURR OPIN NEUROL, vol. 21, 2008, pages 693 - 700 | AUBURGER, GSEN, N. EMEIERHOFER, D.BASAK, A. NGITLER, A. D: "Efficient Prevention of Neurodegenerative Diseases by Depletion of Starvation Response Factor Ataxin-2", TRENDS NEUROSCI, vol. 40, 2017, pages 507 - 516 | ZHANG, D. ET AL.: "A 3D Alzheimer's disease culture model and the induction of P21-activated kinase mediated sensing in iPSC derived neurons.", BIOMATERIALS, vol. 35, 2014, pages 1420 - 1428, XP055394758, DOI: 10.1016/j.biomaterials.2013.11.028 DOI: http://dx.doi.org/10.1016/j.biomaterials.2013.11.028 | KAMPMANN, M: "A CRISPR Approach to Neurodegenerative Diseases.", TRENDS MOL MED, vol. 23, 2017, pages 483 - 485, XP085047744, DOI: 10.1016/j.molmed.2017.04.003 DOI: http://dx.doi.org/10.1016/j.molmed.2017.04.003 | HORLBECK, M. A. ET AL.: "Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation.", ELIFE, 2016, pages 5 | CHEN-PLOTKIN, A. S. ET AL.: "Brain progranulin expression in GRN-associated frontotemporal lobar degeneration.", ACTA NEUROPATHOL, vol. 119, 2010, pages 111 - 122, XP019780682 | HOSAKA, T. ET AL.: "A novel frameshift GRN mutation results in frontotemporal lobar degeneration with a distinct clinical phenotype in two siblings: case report and literature review", BMC NEUROL, vol. 17, 2017, pages 182 | WAUTERS, E.VAN MOSSEVELDE, SVAN DER ZEE, J.CRUTS, M.VAN BROECKHOVEN, C: "Modifiers of GRN-Associated Frontotemporal Lobar Degeneration.", TRENDS MOL MED, vol. 23, 2017, pages 962 - 979, XP085210518, DOI: 10.1016/j.molmed.2017.08.004 DOI: http://dx.doi.org/10.1016/j.molmed.2017.08.004 | HOLLER, C. J. ET AL.: "Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia", MOL NEURODEGENER, vol. 11, 2016, pages 46, XP055362993, DOI: 10.1186/s13024-016-0114-3 DOI: http://dx.doi.org/10.1186/s13024-016-0114-3 | HESTER, M. E. ET AL.: "Rapid and efficient generation of functional motor neurons from human pluripotent stem cells using gene delivered transcription factor codes.", MOL THER, vol. 19, 2011, pages 1905 - 1912, XP055329955, DOI: 10.1038/mt.2011.135 DOI: http://dx.doi.org/10.1038/mt.2011.135 | SHI, Y. ET AL.: "Haploinsufficiency leads to neurodegeneration in COORF72 ALS/FTD human induced motor neurons.", NAT MED, vol. 24, 2018, pages 313 - 325, XP055973357, DOI: 10.1038/nm.4490 DOI: http://dx.doi.org/10.1038/nm.4490 | YANG, N. ET AL.: "Generation of pure GABAergic neurons by transcription factor programming.", NAT METHODS, vol. 14, 2017, pages 621 - 628, XP055539319, DOI: 10.1038/nmeth.4291 DOI: http://dx.doi.org/10.1038/nmeth.4291 | MUFFAT, J. ET AL.: "Efficient derivation of microglia-like cells from human pluripotent stem cells.", NAT MED, vol. 22, 2016, pages 1358 - 1367, XP037104242, DOI: 10.1038/nm.4189 DOI: http://dx.doi.org/10.1038/nm.4189 | PANDYA, H. ET AL.: "Differentiation of human and murine induced pluripotent stem cells to microglia-like cells.", NAT NEUROSCI, vol. 20, 2017, pages 753 - 759, XP055660805, DOI: 10.1038/nn.4534 DOI: http://dx.doi.org/10.1038/nn.4534 | DOUVARAS, P. ET AL.: "Directed Differentiation of Human Pluripotent Stem Cells to Microglia.", STEM CELL REPORTS, vol. 8, 2017, pages 1516 - 1524, XP093301181, DOI: 10.1016/j.stemcr.2017.04.023 DOI: http://dx.doi.org/10.1016/j.stemcr.2017.04.023 | XU, R. ET AL.: "Human iPSC-derived mature microglia retain their identity and functionally integrate in the chimeric mouse brain.", NAT COMMUN, vol. 11, 2020, pages 1577 | HAENSELER, W. ET AL.: "A Highly Efficient Human Pluripotent Stem Cell Microglia Model Displays a Neuronal-Co-culture-Specific Expression Profile and Inflammatory Response.", STEM CELL REPORTS, vol. 8, 2017, pages 1727 - 1742, XP055719426, DOI: 10.1016/j.stemcr.2017.05.017 DOI: http://dx.doi.org/10.1016/j.stemcr.2017.05.017 | MANTLE, J. L.LEE, K. H.: "A differentiating neural stem cell-derived astrocytic population mitigates the inflammatory effects of TNF-alpha and IL-6 in an iPSC-based blood-brain barrier model.", NEUROBIOL DIS, vol. 119, 2018, pages 113 - 120, XP093126662, DOI: 10.1016/j.nbd.2018.07.030 DOI: http://dx.doi.org/10.1016/j.nbd.2018.07.030 | CANFIELD, S. G. ET AL.: "An isogenic blood-brain barrier model comprising brain endothelial cells, astrocytes, and neurons derived from human induced pluripotent stem cells.", J NEUROCHEM, vol. 140, 2017, pages 874 - 888, XP055384422, DOI: 10.1111/jnc.13923 DOI: http://dx.doi.org/10.1111/jnc.13923 | APPELT-MENZEL, A. ET AL.: "Establishment of a Human Blood-Brain Barrier Co-culture Model Mimicking the Neurovascular Unit Using Induced Pluri- and Multipotent Stem Cells.", STEM CELL REPORTS, vol. 8, 2017, pages 894 - 906, XP055691654, DOI: 10.1016/j.stemcr.2017.02.021 DOI: http://dx.doi.org/10.1016/j.stemcr.2017.02.021 | QIAN, T. ET AL.: "Directed differentiation of human pluripotent stem cells to blood-brain barrier endothelial cells.", SCI ADV, vol. 3, 2017, pages e1701679, XP093134780, DOI: 10.1126/sciadv.1701679 DOI: http://dx.doi.org/10.1126/sciadv.1701679 | LIPPMANN, E. S. ET AL.: "Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells.", NAT BIOTECHNO/, vol. 30, 2012, pages 783 - 791, XP055547621, DOI: 10.1038/nbt.2247 DOI: http://dx.doi.org/10.1038/nbt.2247 | ORLOVA, V. V. ET AL.: "Functionality of endothelial cells and pericytes from human pluripotent stem cells demonstrated in cultured vascular plexus and zebrafish xenografts", ARTERIOSCLER THROMB VASC BIOL, vol. 34, 2014, pages 177 - 186, XP008167541, DOI: 10.1161/ATVBAHA.113.302598 DOI: http://dx.doi.org/10.1161/ATVBAHA.113.302598 | KUMAR, A. ET AL.: "Specification and Diversification of Pericytes and Smooth Muscle Cells from Mesenchymoangioblasts.", CELL REP, vol. 19, 2017, pages 1902 - 1916 | BLANCHARD, J. W ET AL.: "Reconstruction of the human blood-brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes.", NAT MED, vol. 26, 2020, pages 952 - 963, XP037173412, DOI: 10.1038/s41591-020-0886-4 DOI: http://dx.doi.org/10.1038/s41591-020-0886-4 | KRENCIK, R.WEICK, J. PLIU, YZHANG, Z. J.ZHANG, S. C: "Specification of transplantable astroglial subtypes from human pluripotent stem cells.", NAT BIOTECHNOL, vol. 29, 2011, pages 528 - 534, XP055259166, DOI: 10.1038/nbt.1877 DOI: http://dx.doi.org/10.1038/nbt.1877 | TCW, J. ET AL.: "An Efficient Platform for Astrocyte Differentiation from Human Induced Pluripotent Stem Cells.", STEM CELL REPORTS, vol. 9, 2017, pages 600 - 614, XP055759046, DOI: 10.1016/j.stemcr.2017.06.018 DOI: http://dx.doi.org/10.1016/j.stemcr.2017.06.018 | KRENCIK ET AL., NAT. PROTOC., vol. 6, no. 11, 2011, pages 1710 - 1717 |